Baikal Skullcap (Scutellaria baicalensis) and osteoarthritis
What 2 graded rows on baikal skullcap (scutellaria baicalensis) agree on for osteoarthritis, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Baikal Skullcap (Scutellaria baicalensis) page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Baikal Skullcap (Scutellaria baicalensis) page, with its PubMed record.
Your question
Baikal Skullcap (Scutellaria baicalensis) and osteoarthritis
2 rows · 323 peopleThey agree: both rows found an improvement.
- CGrade C× 1
- DGrade D× 1
- Rows
- 2
- Trials
- 2
- People
- 323
What the rows share
From the rowsThe best-graded row, grade C, is a randomized trial of 220 people (2010) and found an improvement.
The rows run from 103 to 220 people, published from 2009 to 2010: 2 single studies.
The rows
2 improved- CGrade CKnee osteoarthritis symptoms (WOMAC, timed walk) · Improved
RCT · n 220 · 2010 · Adults with moderate to severe knee osteoarthritis
500 mg twice daily · 12 weeks
More than 90% in both groups reported significant symptom reduction, with no significant efficacy difference between flavocoxid and naproxen. Flavocoxid had fewer upper-gut and oedema adverse events.
Row on the Baikal Skullcap (Scutellaria baicalensis) page · PubMed 20845002 (opens PubMed)
- DGrade DKnee osteoarthritis discomfort and global response · Improved
Pilot RCT · n 103 · 2009 · Adults with moderate knee osteoarthritis
500 mg twice daily · 1 month
Both groups improved significantly (P ≤ .001), with no detectable differences between flavocoxid and naproxen in outcomes or adverse events.
Row on the Baikal Skullcap (Scutellaria baicalensis) page · PubMed 19555810 (opens PubMed)